Compounds > naproxen
Page last updated: 2024-09-04

naproxen and framycetin

naproxen has been researched along with framycetin in 7 studies

Compound Research Comparison

Studies
(naproxen)		Trials
(naproxen)		Recent Studies (post-2010)
(naproxen)		Studies
(framycetin)		Trials
(framycetin)		Recent Studies (post-2010) (framycetin)
4,5511,0571,4298,151460653

Protein Interaction Comparison

ProteinTaxonomynaproxen (IC50)framycetin (IC50)
30S ribosomal protein S6Escherichia coli K-120.032
30S ribosomal protein S7Escherichia coli K-120.032
50S ribosomal protein L15Escherichia coli K-120.032
50S ribosomal protein L10Escherichia coli K-120.032
50S ribosomal protein L11Escherichia coli K-120.032
50S ribosomal protein L7/L12Escherichia coli K-120.032
50S ribosomal protein L19Escherichia coli K-120.032
50S ribosomal protein L1Escherichia coli K-120.032
50S ribosomal protein L20Escherichia coli K-120.032
50S ribosomal protein L27Escherichia coli K-120.032
50S ribosomal protein L28Escherichia coli K-120.032
50S ribosomal protein L29Escherichia coli K-120.032
50S ribosomal protein L31Escherichia coli K-120.032
50S ribosomal protein L31 type BEscherichia coli K-120.032
50S ribosomal protein L32Escherichia coli K-120.032
50S ribosomal protein L33Escherichia coli K-120.032
50S ribosomal protein L34Escherichia coli K-120.032
50S ribosomal protein L35Escherichia coli K-120.032
50S ribosomal protein L36Escherichia coli K-120.032
30S ribosomal protein S10Escherichia coli K-120.032
30S ribosomal protein S11Escherichia coli K-120.032
30S ribosomal protein S12Escherichia coli K-120.032
30S ribosomal protein S13Escherichia coli K-120.032
30S ribosomal protein S16Escherichia coli K-120.032
30S ribosomal protein S18Escherichia coli K-120.032
30S ribosomal protein S19Escherichia coli K-120.032
30S ribosomal protein S20Escherichia coli K-120.032
30S ribosomal protein S2Escherichia coli K-120.032
30S ribosomal protein S3Escherichia coli K-120.032
30S ribosomal protein S4Escherichia coli K-120.032
30S ribosomal protein S5Escherichia coli K-120.032
30S ribosomal protein S8Escherichia coli K-120.032
30S ribosomal protein S9Escherichia coli K-120.032
50S ribosomal protein L13Escherichia coli K-120.032
50S ribosomal protein L14Escherichia coli K-120.032
50S ribosomal protein L16Escherichia coli K-120.032
50S ribosomal protein L23Escherichia coli K-120.032
30S ribosomal protein S15Escherichia coli K-120.032
50S ribosomal protein L17Escherichia coli K-120.032
50S ribosomal protein L21Escherichia coli K-120.032
50S ribosomal protein L30Escherichia coli K-120.032
50S ribosomal protein L6Escherichia coli K-120.032
30S ribosomal protein S14Escherichia coli K-120.032
30S ribosomal protein S17Escherichia coli K-120.032
30S ribosomal protein S1Escherichia coli K-120.032
50S ribosomal protein L18Escherichia coli K-120.032
50S ribosomal protein L2Escherichia coli K-120.032
50S ribosomal protein L3Escherichia coli K-120.032
50S ribosomal protein L24Escherichia coli K-120.032
50S ribosomal protein L4Escherichia coli K-120.032
50S ribosomal protein L22Escherichia coli K-120.032
50S ribosomal protein L5Escherichia coli K-120.032
30S ribosomal protein S21Escherichia coli K-120.032
50S ribosomal protein L25Escherichia coli K-120.032
50S ribosomal protein L36 2Escherichia coli K-120.032

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Campillo, NE; Guerra, A; Páez, JA1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Choudhary, S; Kishore, N; Talele, P1
Antes, AW; Dolhun, EP1

Other Studies

7 other study(ies) available for naproxen and framycetin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:1

    Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics

2011
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Thermodynamic insights into drug-surfactant interactions: Study of the interactions of naporxen, diclofenac sodium, neomycin, and lincomycin with hexadecytrimethylammonium bromide by using isothermal titration calorimetry.
    Colloids and surfaces. B, Biointerfaces, 2015, Aug-01, Volume: 132

    Topics: Calorimetry; Cetrimonium; Cetrimonium Compounds; Diclofenac; Lincomycin; Micelles; Naproxen; Neomycin; Pharmaceutical Preparations; Surface-Active Agents; Thermodynamics

2015
A Case of Cardboard Boxes Likely Facilitating the Biting of a Patient by Trypanosoma cruzi-Infected Triatomine Bugs.
    The American journal of tropical medicine and hygiene, 2016, Nov-02, Volume: 95, Issue:5

    Topics: Adult; Animals; Bacitracin; California; Chagas Disease; Drug Combinations; Humans; Insect Bites and Stings; Insect Vectors; Male; Naproxen; Neomycin; Polymyxin B; Treatment Outcome; Triatoma; Trimethoprim, Sulfamethoxazole Drug Combination; Trypanosoma cruzi

2016